Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: J Surg Oncol. 2011 Apr 25;104(2):155–161. doi: 10.1002/jso.21954

Table III.

Biochemical and Imaging Characteristics before and after Neoadjuvant Therapy

Pre-GTX/IMRT Post-GTX/IMRT p-value

Median CA 19-9 (units/mL) 483 50 <0.01 *
 Range 0–9590 0–5450

Median PET SUV max 5.7 1.6 <0.001 #
 Range 3.4–13.9 0–4

Median Pancreatic Mass Size by CT (cm) 3.35 2.70 0.002
 Range 2.0–5.0 0–5.0
*

8/16 patients had a > 85% decrease in CA 19-9 levels

#

7/14 patients had a 100% decrease in PET SUV max